First Members Appointed to Nevada Cannabis Advisory Commission

NEVADA: Nevada Governor Steve Sisolak announced the appointment of eight members to the Cannabis Advisory Commission (CAC). Established through AB 533, the 12-person commission studies cannabis-related issues and makes recommendations to the Nevada Cannabis Compliance Board (CCB).

Appointees:

  • Benjamin Chew, District Manager, DB Labs
  • James Hammer, General Manager, Wallflower Cannabis House
  • A’Esha Goins, Founder, Cannabis Equity and Inclusion Community (CEIC) Nevada
  • Jillian Nelson, Vice President of Operations, Evergreen Organix
  • Michael Nikhman, Co-Owner, Nevada Group Wellness
  • Kema Ogden, Co-Owner, Top Notch The Health Center
  • Dr. Jennifer Pearson, Assistant Professor, University of Nevada, Reno
  • Daniel Stewart, Attorney, Hutchison & Steffen

The CAC consists of 12 members, eight of which are appointed by the governor. Members are appointed on the merit of their knowledge, skill, and experience either within or outside of the cannabis industry. Combined, appointees represent experts in the cannabis cultivation, retail, laboratory science, and manufacturing spaces, and experts in the law, medical and public health fields alongside advocates of the medical use of cannabis and criminal justice reform.

In addition to the eight gubernatorial appointees, the CAC includes Nevada’s Attorney General, the Director of the Nevada Department of Public Safety (DPS), the Executive Director of the Department of Taxation (DoT), and the Executive Director of the CCB who serves as Chair of the CAC.

Appointees serve a two-year term and are eligible for reappointment.

Nevada CCB Launches Investigations Into Three Nevada Dispensaries, Selling Potentially Unsafe Product

NEVADA: The Nevada Cannabis Compliance Board (CCB) has opened investigations into three dispensaries for selling product that twice failed microbial testing.

On March 5, 2020, the Department of Taxation and CCB issued a directive to all dispensary/retail stores to immediately stop selling the product, Cherry OG F3, which failed laboratory testing for yeast and mold, coliforms, Enterobacteriaceae and Aspergillus.

At that time, the CCB instructed dispensary/retail stores to destroy or return the affected product to the cultivator and communicate that they took such action with the State. Despite the CCB’s directive, it appears three dispensaries retained their inventory of Cherry OG and began selling the product again in May.

Approximately 375 grams of the Cherry OG product were sold between May 19, 2020 and June 29, 2020 at the following Retail Stores/Medical Dispensaries:

1. Waveseer of Las Vegas, LLC (Jenny’s Dispensary), 5530 N Decatur Blvd, Las Vegas, NV 89130 (License # 83760475147127946601);

2. Paradise Wellness Center, LLC (Las Vegas ReLeaf), 2244 Paradise Road, Las Vegas, NV 89104 (License # 54283805068313943868); and

3. Desert Aire Wellness, LLC (Sahara Wellness), 420 E Sahara Ave, Las Vegas, NV 89104 (License # 25729455103203031356)

On May 16, 2020, a hold on the product was temporarily lifted due to a CCB error that occurred during an unrelated investigation. However, the CCB’s health and safety advisory remained in effect; and under the directive, dispensaries should not have had the product in their inventory.

The CCB advises those who have purchased the product to avoid consuming it. Consumers should check any Cherry OG products for the source package # 1A404030000076F000006649. The CCB notified the aforementioned dispensaries and initiated investigations which are ongoing. There are no known reports of illness.